168 participants
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-26
- Start Date:
- 2026-06-01
- Completion:
- 2027-02-28
Conditions
- Hyperphosphatemia
- Chronic Kidney Disease Requiring Chronic Dialysis
- End Stage Renal Disease on Dialysis
Interventions
- DRUG
No Results Yet